Labeling of hu3F8-C825 with Radioactive Iodine and Lutetium-177
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Memorial Sloan Kettering Cancer Center
Variable analysis
- Radiolabeling of hu3F8-C825 with 124I using pre-coated IODOGEN tubes
- Radiolabeling of
p -aminobenzyl-DOTA (DOTA-Bn) with 177LuCl3
- Specific activities of the radiolabeled hu3F8-C825 (121-152 MBq/mg)
- Immunoreactivities of the radiolabeled hu3F8-C825 (78.8 ± 0.1% for GD2(+)-NB IMR-32 and 4.9 ± 0.4% for GD2(-) SK-N-SH)
- Standard protocols for radiolabeling of hu3F8-C825 and DOTA-Bn
- Absence of HPLC purification for the 177Lu-DOTA-Bn due to the lack of recognition of metal-free DOTA-Bn by C825
- GD2(+)-NB IMR-32 cell line for evaluating the immunoreactivity of radiolabeled hu3F8-C825
- GD2(-) SK-N-SH cell line for evaluating the immunoreactivity of radiolabeled hu3F8-C825
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!